Description
Introduction of Cabozantinib 60mg Tablet:
Cabozantinib Tablet is a tyrosine kinase inhibitor used to treat advanced renal cell carcinoma, hepatocellular carcinoma, and medullary thyroid cancer.
Uses of Cabozantinib 60mg Tablet:
- Progressive, metastatic medullary thyroid cancer
- Advanced renal cell carcinoma
- Hepatocellular carcinoma (in patients previously treated with sorafenib)
Benefit of action of Cabozantinib 60mg Tablet:
In Renal Cell Carcinoma, Hepatocellular Carcinoma, and Medullary Thyroid Cancer
Cabozantinib Tablet is indicated for the treatment of progressive, metastatic medullary thyroid cancer, as well as advanced renal cell carcinoma. It is also used for hepatocellular carcinoma in patients who have previously been treated with sorafenib. By blocking multiple receptor tyrosine kinases involved in tumor growth and blood supply, it helps slow or stop cancer progression. Take it exactly as prescribed by your doctor, and discuss any side effects or concerns with your healthcare team.
Mechanism of action of Cazanat 60mg Capsule:
Cabozantinib Tablet inhibits specific receptor tyrosine kinases, including VEGFR-1, -2, and -3, KIT, TRKB, FLT-3, AXL, RET, MET, and TIE-2, which are involved in tumor growth and blood vessel formation.
Reviews
There are no reviews yet.